9MI0
 
 | 61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 61_12A01 heavy chain Fv, ... | Authors: | Phulera, S, Ozorowski, G, Ward, A.B. | Deposit date: | 2024-12-12 | Release date: | 2025-05-21 | Last modified: | 2025-08-13 | Method: | ELECTRON MICROSCOPY (2.8 Å) | Cite: | Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science, 389, 2025
|
|
9MIA
 
 | 206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 206-3G08 heavy chain Fv, ... | Authors: | Phulera, S, Ozorowski, G, Ward, A.B. | Deposit date: | 2024-12-12 | Release date: | 2025-05-21 | Last modified: | 2025-08-13 | Method: | ELECTRON MICROSCOPY (2.8 Å) | Cite: | Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science, 389, 2025
|
|
9MIB
 
 | 206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 206-9C09 heavy chain Fv, ... | Authors: | Phulera, S, Ozorowski, G, Ward, A.B. | Deposit date: | 2024-12-12 | Release date: | 2025-05-21 | Last modified: | 2025-08-13 | Method: | ELECTRON MICROSCOPY (2.8 Å) | Cite: | Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science, 389, 2025
|
|
9MIC
 
 | Crystal structure of the VRC01-class antibody 4D01, derived from GT1.1 vaccination, in complex with eOD-GT8 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 4D01 Fab heavy chain, 4D01 Fab light chain, ... | Authors: | Agrawal, S, Wilson, I.A. | Deposit date: | 2024-12-12 | Release date: | 2025-05-28 | Last modified: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.97 Å) | Cite: | Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science, 389, 2025
|
|
9MID
 
 | Crystal structure of the VRC01-class antibody 3G08, derived from GT1.1 vaccination, in complex with eOD-GT8 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 3G08 Fab Heavy Chain, 3G08 Fab Light Chain, ... | Authors: | Agrawal, S, Wilson, I.A. | Deposit date: | 2024-12-12 | Release date: | 2025-05-28 | Last modified: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.74 Å) | Cite: | Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science, 389, 2025
|
|
9MIF
 
 | Crystal structure of the VRC01-class antibody 9C09, derived from GT1.1 vaccination, in complex with eOD-GT8 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 9C09 Fab heavy chain, 9C09 Fab light chain, ... | Authors: | Agrawal, S, Wilson, I.A. | Deposit date: | 2024-12-12 | Release date: | 2025-05-28 | Last modified: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.93 Å) | Cite: | Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science, 389, 2025
|
|
9MIH
 
 | 273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 273-4D01 heavy chain Fv, ... | Authors: | Phulera, S, Ozorowski, G, Ward, A.B. | Deposit date: | 2024-12-12 | Release date: | 2025-05-21 | Last modified: | 2025-08-13 | Method: | ELECTRON MICROSCOPY (3.9 Å) | Cite: | Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science, 389, 2025
|
|
9MII
 
 | 253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 253-7A03 heavy chain Fv, ... | Authors: | Phulera, S, Ozorowski, G, Ward, A.B. | Deposit date: | 2024-12-12 | Release date: | 2025-05-21 | Last modified: | 2025-08-13 | Method: | ELECTRON MICROSCOPY (3.3 Å) | Cite: | Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science, 389, 2025
|
|
9MIP
 
 | CryoEM structure of the Protein Phasphatase 2A (Aalpha-B56gamma-Calpha) holoenzyme complex | Descriptor: | MANGANESE (II) ION, Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform, Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform, ... | Authors: | Day, A, Taylor, D. | Deposit date: | 2024-12-13 | Release date: | 2025-07-09 | Last modified: | 2025-08-13 | Method: | ELECTRON MICROSCOPY (3.4 Å) | Cite: | Regulatory mechanisms of PP2A complex assembly driven by physicochemical differences in A-subunit isoforms. Structure, 2025
|
|
9MJ3
 
 | Crystal structure of the VRC01-class antibody 12A01, derived from GT1.1 vaccination, in complex with eOD-GT8 | Descriptor: | 12A01 Fab heavy chain, 12A01 Fab light chain, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... | Authors: | Agrawal, S, Wilson, I.A. | Deposit date: | 2024-12-13 | Release date: | 2025-05-28 | Last modified: | 2025-08-13 | Method: | X-RAY DIFFRACTION (2.2 Å) | Cite: | Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science, 389, 2025
|
|
9MJ6
 
 | |
9MJC
 
 | |
9MJD
 
 | |
9MJI
 
 | |
9MK4
 
 | |
9MKO
 
 | 4D4 TCR bound to R-phycoerythrin | Descriptor: | 4D4 TCR alpha chain, 4D4 TCR beta chain, PHYCOERYTHROBILIN, ... | Authors: | Rashleigh, L, Gully, B.S, Rossjohn, J. | Deposit date: | 2024-12-17 | Release date: | 2025-08-06 | Last modified: | 2025-08-13 | Method: | ELECTRON MICROSCOPY (3.21 Å) | Cite: | Antibody-like recognition of a gamma delta T cell receptor toward a foreign antigen. Structure, 2025
|
|
9MLG
 
 | |
9MNN
 
 | Crystal structure of L. monocytogenes MenD with Mg2+ and intermediate I bound | Descriptor: | (4S)-4-{3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-{[(S)-hydroxy(phosphonooxy)phosphoryl]oxy}ethyl)-4-methyl-1,3lambda~5~-thiazol-2-yl}-4-hydroxybutanoic acid, 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase, MAGNESIUM ION | Authors: | Klein, M, Given, F.M, Ho, N.A.T, Allison, T.M, Johnston, J.M. | Deposit date: | 2024-12-22 | Release date: | 2025-07-30 | Last modified: | 2025-08-13 | Method: | X-RAY DIFFRACTION (2.79 Å) | Cite: | Structures of Listeria monocytogenes MenD in ThDP-bound and in-crystallo captured intermediate I-bound forms. Acta Crystallogr.,Sect.F, 81, 2025
|
|
9MSD
 
 | G002-293-0536 Fab in complex with 001428_T278M_L14 SOSIP and RM20A3 Fab | Descriptor: | 001428_T278M_L14 SOSIP gp140, 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... | Authors: | Phulera, S, Ozorowski, G, Ward, A.B. | Deposit date: | 2025-01-09 | Release date: | 2025-05-28 | Last modified: | 2025-08-13 | Method: | ELECTRON MICROSCOPY (3.2 Å) | Cite: | Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans. Science, 389, 2025
|
|
9MSY
 
 | G002-480-0546 Fab in complex with V703-0537_T278M_L14 SOSIP and BG18 Fab | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, BG18 Fab heavy chain, ... | Authors: | Phulera, S, Ozorowski, G, Ward, A.B. | Deposit date: | 2025-01-10 | Release date: | 2025-05-28 | Last modified: | 2025-08-13 | Method: | ELECTRON MICROSCOPY (3.4 Å) | Cite: | Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans. Science, 389, 2025
|
|
9MVO
 
 | Crystal Structure of SARS-CoV-2 Main Protease (Mpro) in Complex with Inhibitor AVI-4692 | Descriptor: | (3M,5P,6M)-5-(1H-1,2,3-benzotriazol-1-yl)-6-(3-chlorophenyl)-3-(isoquinolin-4-yl)-1-(prop-2-en-1-yl)pyrimidine-2,4(1H,3H)-dione, (3M,5P,6M)-5-(1H-1,2,3-benzotriazol-1-yl)-6-(3-chlorophenyl)-3-(isoquinolin-4-yl)-1-(prop-2-yn-1-yl)pyrimidine-2,4(1H,3H)-dione, 3C-like proteinase nsp5 | Authors: | Diallo, A, Gumpena, R, Verba, K. | Deposit date: | 2025-01-15 | Release date: | 2025-07-23 | Last modified: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.84 Å) | Cite: | Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus M Pro inhibitors with potent in vivo efficacy. Sci Adv, 11, 2025
|
|
9MVT
 
 | |
9MVV
 
 | |
9N1S
 
 | Crystal structure of the Transport and Golgi Organization protein 2 Homolog (TANGO2) tetragonal form | Descriptor: | CHLORIDE ION, PHOSPHATE ION, Transport and Golgi organization protein 2 homolog | Authors: | Lovell, S, Cooper, A, Powers, A, Battaile, K.P, Moshen, A.W, Ghaloul-Gonzalez, L. | Deposit date: | 2025-01-27 | Release date: | 2025-04-30 | Last modified: | 2025-08-13 | Method: | X-RAY DIFFRACTION (2.3 Å) | Cite: | The Crystal Structure of Human Transport and Golgi Organization 2 Homolog (TANGO2) Protein Reveals an alpha beta beta alpha-Fold Arrangement. Proteins, 2025
|
|
9N2D
 
 | Cryo-EM structure of an extended F. johnsoniae BAM complex, composite map | Descriptor: | (2~{R},4~{R},5~{R},6~{R})-6-[(1~{R})-1,2-bis(oxidanyl)ethyl]-2-[(2~{R},4~{R},5~{R},6~{R})-6-[(1~{R})-1,2-bis(oxidanyl)ethyl]-5-[(2~{S},3~{S},4~{R},5~{R},6~{R})-6-[(1~{S})-1,2-bis(oxidanyl)ethyl]-4-[(2~{R},3~{S},4~{R},5~{S},6~{R})-6-[(1~{S})-2-[(2~{S},3~{S},4~{S},5~{S},6~{R})-6-[(1~{S})-1,2-bis(oxidanyl)ethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-1-oxidanyl-ethyl]-3,4-bis(oxidanyl)-5-phosphonooxy-oxan-2-yl]oxy-3-oxidanyl-5-phosphonooxy-oxan-2-yl]oxy-2-carboxy-2-[[(2~{R},3~{S},4~{R},5~{R},6~{R})-5-[[(3~{R})-3-dodecanoyloxytetradecanoyl]amino]-6-[[(2~{R},3~{S},4~{R},5~{R},6~{R})-3-oxidanyl-5-[[(3~{R})-3-oxidanyltetradecanoyl]amino]-4-[(3~{R})-3-oxidanyltetradecanoyl]oxy-6-phosphonooxy-oxan-2-yl]methoxy]-3-phosphonooxy-4-[(3~{R})-3-tetradecanoyloxytetradecanoyl]oxy-oxan-2-yl]methoxy]oxan-4-yl]oxy-4,5-bis(oxidanyl)oxane-2-carboxylic acid, Bam A, Bam D, ... | Authors: | Deme, J.C, Lea, S.M. | Deposit date: | 2025-01-28 | Release date: | 2025-07-09 | Last modified: | 2025-08-13 | Method: | ELECTRON MICROSCOPY (2.7 Å) | Cite: | An extended BAM complex in the Bacteroidota To Be Published
|
|